BBIO
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$67.28+$0.37 (+0.55%)
Price as of Oct 02, 2026 4:15 PM EDT
  • $13.1B
    Market Cap
  • 25.58%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 43
Valuation
BBIO
vs History
vs S&P 500
Profitability
-0
Growth
0
Low Earnings Volatility
1

Momentum Score

Score: 34
Valuation
BBIO
vs History
vs S&P 500
3-Month Momentum
2.81%
12-Month Momentum
43.18%
3-Month Risk Adjusted Momentum
14.41%
12-Month Risk Adjusted Momentum
94.54%

True Yield

N/A
Valuation
BBIO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
1.44%
Net Debt Paydown Yield
5.02%

Financial Health Score

Score: 85
Valuation
BBIO
vs History
vs S&P 500
Ohlson's O-Score
5